GCP
ASTH icon

GSA Capital Partners’s Astrana Health ASTH Stock Holding History

GSA Capital Partners’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,896
Closed -$218K – 1980
2023
Q2 		$218K Buy
+6,896
New +$236K 0.02% 1220
2023
Q1 		– Sell
-40,571
Closed -$1.2M – 1992
2022
Q4 		$1.2M Buy
40,571
+16,056
+65% +$516K 0.15% 136
2022
Q3 		$956K Buy
+24,515
New +$1.12M 0.13% 180
2022
Q2 		– Sell
-6,833
Closed -$331K – 1871
2022
Q1 		$331K Buy
+6,833
New +$353K 0.04% 826
2021
Q1 		– Sell
-31,128
Closed -$569K – 1549
2020
Q4 		$569K Buy
31,128
+11,755
+61% +$211K 0.09% 351
2020
Q3 		$348K Buy
+19,373
New +$334K 0.06% 636

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

GSA Capital Partners's ASTH Position: Q3 2023 in Review

GSA Capital Partners sold out of Astrana Health (ASTH) in Q3 2023, closing a stake of 6,896 shares — an estimated $218K sold.

GSA Capital Partners first reported a position in ASTH in Q3 2020 and held it in 6 quarters. The position peaked at $1.2M in Q4 2022. 134 funds tracked by Wall St. Rank hold ASTH as of Q3 2023.

  • GSA Capital Partners reported no remaining Astrana Health position as of Q3 2023 after selling out during the quarter.
  • GSA Capital Partners sold 6,896 Astrana Health shares in Q3 2023, an estimated $218K.
  • GSA Capital Partners first reported a position in Astrana Health in Q3 2020 and held it in 6 quarters.
  • GSA Capital Partners's Astrana Health position peaked at $1.2M in Q4 2022.
  • 134 funds tracked by Wall St. Rank held Astrana Health as of Q3 2023.

Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.